Drug Shortage Report for FASTURTEC
| Report ID | 193234 |
| Drug Identification Number | 02248416 |
| Brand name | FASTURTEC |
| Common or Proper name | FASTURTEC |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RASBURICASE |
| Strength(s) | 1.5MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 3 vials |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-05-26 |
| Actual start date | 2023-05-25 |
| Estimated end date | 2023-09-29 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-09-19 |
| Company comments | Health Canada has allowed the temporary importation and distribution of Great Britain –labelled product to manage this shortage. Due to the limited inventory available there will be some order restrictions. Lot No. 3J1011, Expiry Date:28.02.2026, PLGB 04425/0821 Please contact LAVALCS@sanofi.com in case of questions. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2023-05-26 | English | Compare |
| v2 | 2023-05-26 | French | Compare |
| v3 | 2023-06-09 | English | Compare |
| v4 | 2023-06-09 | French | Compare |
| v5 | 2023-06-09 | English | Compare |
| v6 | 2023-06-09 | French | Compare |
| v7 | 2023-07-21 | English | Compare |
| v8 | 2023-07-21 | French | Compare |
| v9 | 2023-09-19 | English | Compare |
| v10 | 2023-09-19 | French | Compare |
Showing 1 to 10 of 10